NDC 68788-8563-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-8563
- Requested NDC
- 68788-8563-01
- Package NDCs from labels
- 68788-8563-3, 68788-8563-6, 68788-8563-9, 68788-8563-1, 68788-8563-8, 68788-8563-01
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-04-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2026-04-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-8563-1 | Gabapentin | 100 in 1 BOTTLE, PLASTIC | CAPSULE | 100 | 3 | |
| 68788-8563-3 | Gabapentin | 30 in 1 BOTTLE, PLASTIC | CAPSULE | 30 | 3 | |
| 68788-8563-6 | Gabapentin | 60 in 1 BOTTLE, PLASTIC | CAPSULE | 60 | 3 | |
| 68788-8563-8 | Gabapentin | 120 in 1 BOTTLE, PLASTIC | CAPSULE | 120 | 3 | |
| 68788-8563-9 | Gabapentin | 90 in 1 BOTTLE, PLASTIC | CAPSULE | 90 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-8563 | GABAPENTIN CAPSULE [PREFERRED PHARMACEUTICALS INC.] | 1 | Current NDC, 5 package rows | 20240206_2625c0ef-5295-41de-9e81-88001a6cbecc.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-8563-1 | EA - Each | 68788-8563 | 2d1f267e-3ef0-40a5-909c-b3d4c50e2862 | 1 | 2024-05-16 |
| 68788-8563-3 | EA - Each | 68788-8563 | b1437b10-b861-44f9-978a-5bc2b13193f3 | 1 | 2024-05-16 |
| 68788-8563-6 | EA - Each | 68788-8563 | 202d078f-b330-4a18-a7dd-a3b5820525eb | 1 | 2024-05-16 |
| 68788-8563-8 | EA - Each | 68788-8563 | 90fccd51-866b-40bb-bb13-63eabd8c8072 | 1 | 2024-05-16 |
| 68788-8563-9 | EA - Each | 68788-8563 | 47068409-e4a7-4d55-bb57-f3418778c8ca | 1 | 2024-05-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 48037fc4-1aab-4ae8-aede-7c55b494877a | 2026-08-07 | Warnings, Adverse reactions | ANDA204989 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | ddb3a54f-5224-4024-8804-b2a2f01d885e | 2026-08-06 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | fce0c123-29d7-42bf-8c8d-8be1772e2d99 | 2026-08-06 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| EltaMD UV Restore | TITANIUM DIOXIDE, ZINC OXIDE SUNSCREEN | CP Skin Health Group, Inc | 37fee381-ce6b-4949-9a4a-778aa839fb84 | 2026-08-06 | Warnings | 15FIX9V2JP |
| Gabapentin | GABAPENTIN | Coupler LLC | 583ab038-7b6e-96f8-e063-6294a90adf47 | 2026-08-04 | Warnings, Adverse reactions | 6CW7F3G59X |
| Luxe Gloss Hydrating Lip Gloss SPF 35-NAKED HONEY | OCTOCRYLENE 8%, OCTISALATE 5%, TITANIUM DIOXIDE 6%, ZINC OXIDE 8% | Lale Cosmetics LLC | 581fb0cd-c55d-d562-e063-6394a90a7f11 | 2026-08-03 | Warnings | 15FIX9V2JP |
| EltaMD UV Active | ZINC OXIDE AND TITANIUM DIOXIDE SUNSCREEN | CP Skin Health Group, Inc | 39d16479-d491-4c19-aa11-674461687c7b | 2026-08-03 | Warnings | 15FIX9V2JP |
| Continuous Correction Cream | TITANIUM DIOXIDE | Baxter of California, LLC | 1cbcc648-f2e1-af60-e063-6294a90ad4bb | 2026-07-31 | Warnings | 15FIX9V2JP |
| Cover Creme | TITANIUM DIOXIDE | Baxter of California | 31f5e8c4-523f-4596-e063-6294a90a6a12 | 2026-07-31 | Warnings | 15FIX9V2JP |
| GABAPENTIN | GABAPENTIN | TIME CAP LABORATORIES, INC | 08880902-bd44-41b6-866b-2cbad4c3f2b1 | 2026-07-30 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 81243958-cc5a-4ec0-a64d-71682f949d5f | 2026-07-30 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | bc525ae4-9843-4038-a1b7-0d3543e2282c | 2026-07-30 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Cardinal Health 107, LLC | 41844c21-9e2a-4332-a8ff-9b71ae9032b0 | 2026-07-30 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | TAGI Pharma, Inc. | 725878fa-1e2f-4fee-a9e1-a6e102c79625 | 2026-07-28 | Warnings, Adverse reactions | 6CW7F3G59X |
| ESIKA COLORFIX POLVOS 32H POLVO COMPACTO FACIAL DE ALTA COBERTURA FPS 15 110-C | OCTINOXATE, TITANIUM DIOXIDE, ZINC OXIDE | BEL STAR S.A. | 575fb2c3-e332-8a3b-e063-6394a90a9fd9 | 2026-07-24 | Warnings | 15FIX9V2JP |
| Gabapentin | GABAPENTIN | Ascend Laboratories, LLC | 722de2a9-38b3-4518-b262-ba0d1346d0ba | 2026-07-24 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 5a78ab50-993d-4857-be10-be665e02b353 | 2026-07-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| True Coast SPF 50 Mineral Sunscreen | ZINC OXIDE 18%, TITANIUM DIOXIDE 6% | Foshan Sugar Max Cosmetics CO.,Ltd | 5379466d-8d14-5fc2-e063-6394a90abd7e | 2026-07-22 | Warnings | 15FIX9V2JP |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals, Inc. | 57383d2a-d2c7-bbdc-e063-6294a90ada98 | 2026-07-22 | Warnings, Adverse reactions | 6CW7F3G59X |
| Yves Saint Laurent All Hours Foundation Sunscreen Broad Spectrum SPF 30 Luminous Matte Foundation | OCTINOXATE AND TITANIUM DIOXIDE | SICOS ET CIE | 571f23e9-1126-e32d-e063-6294a90a9951 | 2026-07-21 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.